CiteULike: guhjy's Solomon:SD [8 articles]

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease.

The New England journal of medicine (30 October 2009)

posted to rct outcome epo dm ckd by guhjy on 2009-11-09 14:02:21 as

Albuminuria in chronic heart failure: prevalence and prognostic importance.

Lancet, Vol. 374, No. 9689. (15 August 2009), pp. 543-550.

by Colette E. Jackson, Scott D. Solomon, Hertzel C. Gerstein, et al.Sofia Zetterstrand, Bertil Olofsson, Eric L. Michelson, Christopher B. Granger, Karl Swedberg, Marc A. Pfeffer, Salim Yusuf, John J. McMurray, CHARM Investigators and Committees

posted to uae rct chf arb by guhjy on 2009-09-23 00:46:19 as

Dual Renin-Angiotensin System Blockade and Kidney Disease

J Am Coll Cardiol, Vol. 54, No. 3. (14 July 2009), pp. 278-a-279.

by Hans-Henrik Parving, Barry M. Brenner, John J. V. Mcmurray, et al.Dick de Zeeuw, Steven M. Haffner, Scott D. Solomon, Nish Chaturvedi, Marc A. Pfeffer

posted to ckd aceiarb by guhjy on 2009-09-03 04:48:41 as

Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.

Lancet, Vol. 369, No. 9579. (23 June 2007), pp. 2079-2087.

by S. D. Solomon, R. Janardhanan, A. Verma, et al.M. Bourgoun, W. L. Daley, D. Purkayastha, Y. Lacourcière, S. E. Hippler, H. Fields, T. Z. Naqvi, S. L. Mulvagh, J. M. Arnold, J. D. Thomas, M. R. Zile, G. P. Aurigemma,

posted to arb bp chf diastolic rct by guhjy on 2008-10-02 11:00:02 as

Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.

Circulation, Vol. 114, No. 1. (4 July 2006), pp. 26-31.

by S. D. Solomon, M. M. Rice, K. A Jablonski, et al.P. Jose, M. Domanski, M. Sabatine, B. J. Gersh, J. Rouleau, M. A. Pfeffer, E. Braunwald,

posted to acei ckd peace rct by guhjy on 2008-09-25 09:14:08 as

Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.

European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 10, No. 2. (February 2008), pp. 157-163.

by R. A. Weir, J. J. McMurray, M. Puu, et al.S. D. Solomon, B. Olofsson, C. B. Granger, S. Yusuf, E. L. Michelson, K. Swedberg, M. A. Pfeffer,

posted to acei arb chf rct aceiarb by guhjy on 2008-07-21 04:10:12 as

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.

Circulation, Vol. 115, No. 24. (19 June 2007), pp. 3111-3120.

by E. O'Meara, T. Clayton, M. B. McEntegart, et al.J. J. McMurray, I. L. Piña, C. B. Granger, J. Ostergren, E. L. Michelson, S. D. Solomon, S. Pocock, S. Yusuf, K. Swedberg, M. A. Pfeffer,

posted to arb chf gender rct by guhjy on 2008-07-21 04:09:11 as

Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease.

Circulation, Vol. 116, No. 23. (4 December 2007), pp. 2687-2693.

by S. D. Solomon, J. Lin, C. G. Solomon, et al.K. A. Jablonski, M. M. Rice, M. Steffes, M. Domanski, J. Hsia, B. J. Gersh, J. M. Arnold, J. Rouleau, E. Braunwald, M. A. Pfeffer,

posted to cad cv uae by guhjy on 2007-12-14 15:19:55 as

	A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease. [My Copy] The New England journal of medicine (30 October 2009) by Marc A. Pfeffer, Emmanuel A. Burdmann, Chao-Yin Y. Chen, et al.Mark E. Cooper, Dick de Zeeuw, Kai-Uwe U. Eckardt, Jan M. Feyzi, Peter Ivanovich, Reshma Kewalramani, Andrew S. Levey, Eldrin F. Lewis, Janet B. McGill, John J. McMurray, Patrick Parfrey, Hans-Henrik H. Parving, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert Toto, the TREAT Investigators posted to rct outcome epo dm ckd by guhjy on 2009-11-09 14:02:21 as along with 1 person benjaminbertrand
	Albuminuria in chronic heart failure: prevalence and prognostic importance. [My Copy] Lancet, Vol. 374, No. 9689. (15 August 2009), pp. 543-550. by Colette E. Jackson, Scott D. Solomon, Hertzel C. Gerstein, et al.Sofia Zetterstrand, Bertil Olofsson, Eric L. Michelson, Christopher B. Granger, Karl Swedberg, Marc A. Pfeffer, Salim Yusuf, John J. McMurray, CHARM Investigators and Committees posted to uae rct chf arb by guhjy on 2009-09-23 00:46:19 as
	Dual Renin-Angiotensin System Blockade and Kidney Disease [My Copy] J Am Coll Cardiol, Vol. 54, No. 3. (14 July 2009), pp. 278-a-279. by Hans-Henrik Parving, Barry M. Brenner, John J. V. Mcmurray, et al.Dick de Zeeuw, Steven M. Haffner, Scott D. Solomon, Nish Chaturvedi, Marc A. Pfeffer posted to ckd aceiarb by guhjy on 2009-09-03 04:48:41 as
	Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. [My Copy] Lancet, Vol. 369, No. 9579. (23 June 2007), pp. 2079-2087. by S. D. Solomon, R. Janardhanan, A. Verma, et al.M. Bourgoun, W. L. Daley, D. Purkayastha, Y. Lacourcière, S. E. Hippler, H. Fields, T. Z. Naqvi, S. L. Mulvagh, J. M. Arnold, J. D. Thomas, M. R. Zile, G. P. Aurigemma, posted to arb bp chf diastolic rct by guhjy on 2008-10-02 11:00:02 as
	Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. [My Copy] Circulation, Vol. 114, No. 1. (4 July 2006), pp. 26-31. by S. D. Solomon, M. M. Rice, K. A Jablonski, et al.P. Jose, M. Domanski, M. Sabatine, B. J. Gersh, J. Rouleau, M. A. Pfeffer, E. Braunwald, posted to acei ckd peace rct by guhjy on 2008-09-25 09:14:08 as
	Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. [My Copy] European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 10, No. 2. (February 2008), pp. 157-163. by R. A. Weir, J. J. McMurray, M. Puu, et al.S. D. Solomon, B. Olofsson, C. B. Granger, S. Yusuf, E. L. Michelson, K. Swedberg, M. A. Pfeffer, posted to acei arb chf rct aceiarb by guhjy on 2008-07-21 04:10:12 as
	Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. [My Copy] Circulation, Vol. 115, No. 24. (19 June 2007), pp. 3111-3120. by E. O'Meara, T. Clayton, M. B. McEntegart, et al.J. J. McMurray, I. L. Piña, C. B. Granger, J. Ostergren, E. L. Michelson, S. D. Solomon, S. Pocock, S. Yusuf, K. Swedberg, M. A. Pfeffer, posted to arb chf gender rct by guhjy on 2008-07-21 04:09:11 as
	Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. [My Copy] Circulation, Vol. 116, No. 23. (4 December 2007), pp. 2687-2693. by S. D. Solomon, J. Lin, C. G. Solomon, et al.K. A. Jablonski, M. M. Rice, M. Steffes, M. Domanski, J. Hsia, B. J. Gersh, J. M. Arnold, J. Rouleau, E. Braunwald, M. A. Pfeffer, posted to cad cv uae by guhjy on 2007-12-14 15:19:55 as

guhjy's Solomon:SD [8 articles] Export

guhjy's tags

ckd	1734
rct	1195
dn	1078
dm	997
cancer	988
ma	969
cv	905
hd	856
tgfb	791
snp	760
bp	633
ros	570
meta-analysis	515
uae	498
stats	476
kidney	473
software	460
mouse	454
genetics	444
mirna	442
pt	417
proteomics	409
mortality	408
inflammation	363
fbl	359
proteinuria	355
rat	355
pcr	348
tw	345
acei	330
db	326
gdl	325
test	325
urine	315
inhibitor	315
arb	312
method	311
ms	309
apoptosis	302
hcv	300
mc	299
age	298
r	291
aging	287
biomarker	285
irs	280
ppi	275
bias	274
akt	274
bayes	273
gwa	267
mtor	266
aki	265
aii	261
hg	258
nutrition	255
rnai	242
emt	242
ub	237
p53	231
fibrosis	231
egfr	230
cox	226
smad	221
pbmc	220
obesity	219
pi3k	214
metab	212
drug	211
hcc	210
gn	208
1	204
hypoxia	204
herb	197
erk	190
albumin	189
lc	185
collagen	182
longitudinal	179
hif	179
lmm	178
nfkb	176
stz	176
gfr	174
ua	170
pubmed	169
epigenetics	169
japan	165
p38	162
gender	162
cea	160
power	159
lead	159
rage	159
cadmium	158
dna-damage	157
bioinf	155
ref	154
genomics	148
stata	147
vitamin-d	146
ctgf	144
network	142
liver	138
screening	137
rt	135
diet	133
seq	131
company	129
protein	128
phosphorylation	127
go	125
systems-biology	124
pathway	122
cell-cycle	121
no	120
mt	120
book	119
esrd	117
lipid	117
pkc	117
creatinine	115
statin	114
kinase	113
senescence	106
proliferation	105
podocyte	105
s6k	104
fish	103
mapk	103
regression	103
pd	102
gfr-formula	102
case-control	102
imputation	101
cad	100
imaging	99
rx	97
plasmid	97
multiplicity	96
insulin	96
cloning	96
pediatric	95
observational	95
methylation	95
p21	95
recurrent	94
sirt	93
betel	91
blood	91
nhanes	90
nox	90
tnf	90
pparg	89
website	89
toxicology	88
phenotype	88
chf	88
diagnosis	87
anemia	87
cytokine	87
immunity	86
src	86
stat	85
uti	85
at1	84
lr	84
china	83
epo	82
p	81
oat	81
nonp	81
hapmap	80
cachexia	80
environment	79
ca	79
ebm	79
gout	78
hypertrophy	78
primer	78
qms	76
review	75
missing	73
autophagy	73
gene-therapy	73
promoter	73
ko	72
lpd	72
eqtl	72
gene-list	72
surrogate	72
mv	71
ace	71
salt	70
egf	69
phd	69
stone	69
signaling	68
cox2	68
mgo	66
uncertainty	66
mirna-target	65
tin	65
normalization	65
association	64
acid-base	63
yeast	63
causation	63
glycemia	63
foxo	63
enddysf	63
chinese	63
2dge	62
simulation	62
jnk	62
me	62
smoking	62
gpcr	61
hts	61
confounding	61
pla2	61
ptm	61
sas	60
change	60
outcome	60
uuo	60
melamine	60
pe	60
avf	60
oral	59
cost	59
eif	59
shc	59
infection	59
ifn	59
mmp	58
alcohol	58
crp	58
pai1	57
robust	57
urate-transporter	57
achr	57
fluorescence	57
nrk49f	57
llcpk1	57
pls	57
model-selection	56
semantic	56
calibration	56
pdgf	56
hk2	56
hsp	56
aceiarb	56
competing-risk	55
oglcnac	55
ratio	55
goldstd	55
bone	54
iron	54
function	54
estrogen	54
workflow	54
p-value	54
renoprotection	53
std	53
ckd-progression	53
dipstick	53
k	53
stem-cell	53
qc	52
rho	52
ncrna	52
histone	52
ace2	52
lod	51
fgf	51
pth	51
atm	51
normoalbuminuria	51
vegf	51
dimerization	51
epidemiology	51
arsenic	50
cyclin-d1	50
matlab	50
reasoning	50
mercury	50
risk-ratio	50
gene-environment	49
antibiotics	49
graph	49
adpkd	49
hsc	49
ab	49
epistasis	49
tf	49
nrk52e	48
pld	48
core-curriculum	48
klotho	48
ukm	48
breakpoint	48
joint-model	47
ffpe	47
endothelium	47
ngal	47
mesangial	47
protein-microarray	47
spot-urine	47
pooling	47
p27	46
cystatin	46
dub	46
aspirin	46
ecm	46
hdac	46
fdr	46
hgf	46
4ebp	46
il6	46
writing	45
ras	45
rapamycin	45
translation	45
aldosterone	45
prevention	45
fgf23	45
semip	45
metal	45
biosensor	45
ancova	44
variability	44
wnt	44
sle	43
bia	43
klf	43
enos	43
interaction	43
na	43
cnv	43
design	43
agreement	42
sumo	42
icu	42
roc	42
bmi	42
good	42
ccb	42
diuretics	41
stroke	41
er-stress	41
tgfbr	41
wga	40
fuzzy	40
ampk	40
dbdb	40
igf	40
alignment	40
gene-targeting	40
risk	40
dry-bw	39
hepatocyte	39
hyperfiltration	39
qtl	39
urinalysis	38
asia	38
myc	38
igan	38
sage	38
ap1	38
protein-complex	38
tea	37
antisense	37
tlr	37
fabp	37
bh4	37
propensity	37
animal	37
hematuria	37
mtorc1	37
haplotype	37
adh	37
angiogenesis	37
cardiorenal	36
web20	36
emr	36
catenin	36
rsk	36
adenosine	36
omics	36
inflammasome	36
megalin	36
cre	35
candidate-gene	35
s100b	35
adduct	35
subgroup	35
annotation	35
gsk	35
proteasome	35
chemogenomics	35
cross-species	34
calcification	34
pathology	34
attrition	34
threshold	34
sepsis	34
reverse-epidemiology	34
msm	34
nephrotoxicity	33
fibronectin	33
zeb	33
sarcopenia	33
rca	33
integrin	33
cage	33
sp1	33
coffee	33
snx	33
exercise	33
ns	33
effect-size	32
zfn	32
text-mining	32
end-point	32
browser	32
affy	32
addgene	32
orbitrap	32
il1	32
fc	31
transactivation	31
steroid	31
heritability	31
frailty	31
gllamm	31
macrophage	31
emsa	31
hospitalization	31
ecology	31
family	31
risk-difference	31
set	31
blast	31
vsmc	31
membrane-protein	30
bmp	30
notch	30
staging	30
knockout	30
carcinogen	30
rtk	30
creb	30
abp	30
mw	30
irs1	30
silac	30
transporter	30
virus	29
et	29
grn	29
validation	29
ai	29
pka	29
extraction	29
3	29
nicotinic	29
nutrient	29
s100	29
rvh	29
reporter	29
mutagenesis	28
perindopril	28
race	28
geo	28
acetylation	28
time-dependent	28
scaling	28
ub-ligase	28
gee	28
ndrd	27
ck2	27
spla2	27
classification	27
cari	27
ce	27
human	27
pdz	27
mendelian	27
thesis	27
hba1c	26
mtorc2	26
metagenomics	26
muscarinic	26
gsh	26
thp	26
hplc	26
hyaluronan	26
renin	26